CC
The Chemours Company
NYSE · Basic Materials · Chemicals - Specialty · US
$15.45
−0.23%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
9.8x
EV/EBITDA
−34.8x
Market Cap
$2.32B
MomentumView details →
1D Return
−0.23%
YTD Return
+31.64%
RSI (14)
45.1
ValuationView details →
P/E (Fwd)
9.8x
EV/EBITDA
−34.8x
Market Cap
$2.32B
RSI (14)
45.1
MomentumView details →
1D Return
−0.23%
YTD Return
+31.64%
SummaryUpdated Jun 1, 2026
The Chemours Company (NYSE:CC) is a specialty chemicals manufacturer that was spun off from DuPont in 2015. Founded in 2014 and headquartered in Wilmington, Delaware, Chemours operates as an independent company focused on performance chemicals across diverse industrial and consumer applications. The company has evolved from its DuPont heritage to become a focused specialty chemicals provider, though it has faced significant challenges including legacy environmental liabilities, market cyclicality, and high debt levels stemming from its spinoff structure.
Similar companies
Latest newsMore news →
BlackRock Inc. acquired a new position of 23,283,074 shares in The Chemours Company, valued at approximately $477,769,000, according to its 13F filing.10d agoRobeson County government stated that water contamination near the Robeson County Landfill likely originates from the Fayetteville Works plant, not the landfill, and is involved in two lawsuits: one as plaintiff against Chemours and other companies over PFAS pollution, and one as defendant sued by the Southern Environmental Law Center seeking injunctive relief.17d agoMore than 2,600 North Carolina residents reached a settlement with Chemours and DuPont over PFAS contamination, resolving a lawsuit that alleged the companies released PFAS chemicals in the Gray's Creek area since the 1980s, causing property devaluation and loss of ability to grow produce.38d ago